Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity

author
created [InstanceEdit:2399727] Orlic-Milacic, M, 2012-07-12
dbId 2399826
displayName Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
journal Mol. Cancer Ther.
pages 1851-63
pubMedIdentifier 18606717
schemaClass LiteratureReference
title Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
url http://www.ncbi.nlm.nih.gov/pubmed/18606717
volume 7
year 2008
Cite Us!